Japan dyslipidemia cases to reach 15.3 million by 2035

Published: 48 minutes ago Photo by Anirudh via Unsplash Japan dyslipidemia cases to reach 15.3 million by 2035 Japan and France's lower prevalence rates were linked to fewer risk factors such as obesity.

Japan is projected to have approximately 15.3 million diagnosed prevalent cases of dyslipidemia in 2035, according to GlobalData .

The number of diagnosed cases across the seven major markets (7MM) is forecast to increase at an annual growth rate (AGR) of 0.58%, from 131.6 million in 2025 to 139.2 million in 2035.

Dyslipidemia is a medical condition characterised by abnormal levels of lipids in the bloodstream, including cholesterol, low-density lipoprotein cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C).

In its latest report, Dyslipidemia: Epidemiology Forecast to 2035, GlobalData estimated that the US would have over 61.4 million diagnosed cases in 2035, the highest number amongst individual countries in the 7MM.